loading

Calidi Biotherapeutics Inc Borsa (CLDI) Ultime notizie

pulisher
08:02 AM

Calidi Biotherapeutics Presents systemic oncolytic platform - GlobeNewswire

08:02 AM
pulisher
08:00 AM

Revolutionary Cancer Treatment Breakthrough: Calidi's New Systemic Delivery Platform Wows ASCO Conference - Stock Titan

08:00 AM
pulisher
Jun 01, 2025

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock - The Globe and Mail

Jun 01, 2025
pulisher
May 30, 2025

Calidi Biotherapeutics (NYSE:CLDI) Shares Down 5.3% – Time to Sell? - Defense World

May 30, 2025
pulisher
May 16, 2025

Calidi Biotherapeutics, Inc. (CLDI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - Yahoo Finance

May 16, 2025
pulisher
May 14, 2025

Calidi Biotherapeutics Reports First Quarter 2025 Financial Results And Recent Operational Highlights - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Calidi Biotherapeutics Secures FDA Green Light for Cancer Trial as New CEO Reveals Q1 Financials - Stock Titan

May 14, 2025
pulisher
May 07, 2025

Candel Therapeutics (NASDAQ:CADL) vs. Calidi Biotherapeutics (NYSE:CLDI) Critical Review - Defense World

May 07, 2025
pulisher
May 04, 2025

Geode Capital Management LLC Buys 120,406 Shares of Calidi Biotherapeutics, Inc. (NYSE:CLDI) - Defense World

May 04, 2025
pulisher
May 01, 2025

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5 - The Globe and Mail

May 01, 2025
pulisher
Apr 29, 2025

Calidi Biotherapeutics (NYSE:CLDI) Stock Price Down 0.3% – Time to Sell? - Defense World

Apr 29, 2025
pulisher
Apr 29, 2025

Investor’s Delight: Calidi Biotherapeutics Inc (CLDI) Closes Weak at 0.65, Down -6.53 - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

Calidi (CLDI) Advances Cancer Treatment with IL15 Superagonist a - GuruFocus

Apr 29, 2025
pulisher
Apr 28, 2025

Calidi Biotherapeutics Announces IL15 Superagonist as First - GlobeNewswire

Apr 28, 2025
pulisher
Apr 28, 2025

Revolutionary Cancer Treatment Platform Shows Complete Tumor Elimination: First Systemic Delivery Success - Stock Titan

Apr 28, 2025
pulisher
Apr 25, 2025

Calidi Biotherapeutics (CLDI) Awards Stock Option to New CEO Eri - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - The Manila Times

Apr 25, 2025
pulisher
Apr 25, 2025

Calidi Bio's Strategic Move: New CEO Secures 726K Share Options with 4-Year Performance Lock - Stock Titan

Apr 25, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics appoints new CEO By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 23, 2025

Zealand names former Lilly exec Singh as CSO - BioCentury

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics appoints new CEO - Investing.com

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi (CLDI) Appoints New CEO as Eric Poma Assumes Leadership | - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics Appoints New CEO Eric Poma - TipRanks

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics Announces Chief Executive Officer Transition And Appointment Of Eric Poma, Ph.D. As CEO And Director - TradingView

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics Announces Chief Executive Officer - GlobeNewswire

Apr 23, 2025
pulisher
Apr 23, 2025

New Calidi Bio CEO Brings $400M Funding Success Record: Strategic Shift for Cancer Treatment Pioneer - Stock Titan

Apr 23, 2025
pulisher
Apr 22, 2025

Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor - The Globe and Mail

Apr 22, 2025
pulisher
Apr 22, 2025

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on April 24 - The Manila Times

Apr 22, 2025
pulisher
Apr 22, 2025

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24 - GlobeNewswire

Apr 22, 2025
pulisher
Apr 22, 2025

Cancer Breakthrough Alert: Top Oncologist Reveals New FDA-Cleared Stem Cell Therapy Development - Stock Titan

Apr 22, 2025
pulisher
Apr 17, 2025

Calidi Biotherapeutics Announces FDA Clearance of IND Application for CLD-201 in Solid Tumors - The Manila Times

Apr 17, 2025
pulisher
Apr 17, 2025

FDA Green Lights Revolutionary Cancer Treatment: Stem Cells Combined With Virus to Fight Multiple Tumors - Stock Titan

Apr 17, 2025
pulisher
Apr 10, 2025

Calidi Biotherapeutics Announces Appointment of Guy Travis - GlobeNewswire

Apr 10, 2025
pulisher
Apr 10, 2025

Cancer Drug Developer Calidi Bio Strengthens Leadership: Renowned Oncologist Takes CMO Role - Stock Titan

Apr 10, 2025
pulisher
Apr 10, 2025

Calidi Biotherapeutics Appoints New Chief Medical Officer - TipRanks

Apr 10, 2025
pulisher
Apr 08, 2025

CLDI stock touches 52-week low at $0.42 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

CLDI stock touches 52-week low at $0.42 amid market challenges - Investing.com India

Apr 08, 2025
pulisher
Apr 08, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 05, 2025

ASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Apr 05, 2025
pulisher
Apr 05, 2025

HighTower Advisors LLC Makes New Investment in Calidi Biotherapeutics, Inc. (NYSE:CLDI) - Defense World

Apr 05, 2025
pulisher
Apr 01, 2025

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Operational Highlights - The Manila Times

Apr 01, 2025
pulisher
Mar 31, 2025

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

CLDI stock plunges to 52-week low, hitting $0.57 amid market challenges By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Calidi Bio Raises Fresh $3.9M Capital to Advance Clinical Programs - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Calidi Biotherapeutics Cuts Losses by 50% While Expanding Cancer Gene Therapy Trials - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

CLDI stock plunges to 52-week low, hitting $0.57 amid market challenges - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Virtu Financial LLC Buys Shares of 73,448 Calidi Biotherapeutics, Inc. (NYSE:CLDI) - Defense World

Mar 31, 2025
pulisher
Mar 29, 2025

Calidi Biotherapeutics sinks after pricing $3.9M registered direct offering - MSN

Mar 29, 2025
$1.0846
price down icon 1.76%
$29.97
price down icon 0.70%
$577.79
price up icon 0.89%
$305.23
price down icon 0.07%
$4.47
price down icon 2.22%
$489.50
price down icon 0.11%
Capitalizzazione:     |  Volume (24 ore):